Vertex Pharmaceuticals · Buy signal, week 3
Vertex Pharmaceuticals drops 8.1% but rebounds off a double bottom near 427
Vertex Pharmaceuticals · Buy signal, week 3
Our view last week
Vertex Pharmaceuticals is in week 2 of a fresh buy signal, and the trade is already up 16.9% since entry: the first of the 3 targets of our most advanced model has been hit. The week-1 confirmation closed higher, and the weekly picture stays solid, with price hugging its all-time high.
This week's summary
Vertex Pharmaceuticals shares gave back 8.1% this week, after last week's 16.9% surge that already hit the first of the 3 targets of our most advanced model. Price touched a double bottom in the 427 area and bounced 8% off it, but sellers ruled the last session's trade: the bounce isn't confirmed by volume yet. The trade is still up 7.5%.
IQS Phase
59
ordinary
Signal Strength
66
medium
Sizing
STANDARD
Ranking
#32 / 129
US stocks in progress
Trade P&L %
+7.48%
from signal to today
restricted Platinum content